A case of septicemia caused by Pseudomonas stutzeri belonging to the unusual biotype Vb-3 in a patient with multiple myeloma is described. The origin of the septicemia was attributed to a community-acquired pneumonia. The bacteriology and pathogenicity of P. stutzeri are reviewed.
oncology ward. The leukocyte count was 5,500/mm3, with 94% neutrophils. Other results showed hemoglobin, 9 .3 g/dl; blood urea nitrogen, 80 mg/dl; creatinine, 1 (1) , the organism was susceptible to polymyxin, ampicillin, ticarcillin, cefotaxime, ceftazidime, aztreonam, netilmicin, gentamicin, tobramycin, amikacin, trimethoprim-sulfamethoxazole, doxycycline, minocycline, and norfloxacin and resistant to penicillin, cefazolin, cefuroxime, and chloramphenicol. The MICs and MBCs were as follows: cefotaxime, 0.39 ,ug/ml; ceftazidime, 0.048 ,ug/ml; and aztreonam, 0.195 ,ug/ml. Most striking and characteristic of the P. stutzeri isolates were the rough, wrinkled colonies, the denitrification of nitrates to gas (nitrogen), the extracellular amylase activity, and the ability to grow at 42°C and in 6.5% NaCl broth. Our strain produced arginine dihydrolase and, consequently, belongs to the rare biotype Vb-3 (6) . Gilardi found only a 5% frequency of this catabolic activity (Gilardi, 
